Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis.


Journal article


Jonathan C Markle, Anil Johanis, Jacqueline K. Shaia, Daniel Benito, Katherine E. Talcott, Rishi P. Singh
Eye, 2024

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Markle, J. C., Johanis, A., Shaia, J. K., Benito, D., Talcott, K. E., & Singh, R. P. (2024). Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis. Eye.


Chicago/Turabian   Click to copy
Markle, Jonathan C, Anil Johanis, Jacqueline K. Shaia, Daniel Benito, Katherine E. Talcott, and Rishi P. Singh. “Risk of Audiologic Side Effects with Teprotumumab Treatment for Thyroid Eye Disease: Propensity Matched Analysis.” Eye (2024).


MLA   Click to copy
Markle, Jonathan C., et al. “Risk of Audiologic Side Effects with Teprotumumab Treatment for Thyroid Eye Disease: Propensity Matched Analysis.” Eye, 2024.


BibTeX   Click to copy

@article{jonathan2024a,
  title = {Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis.},
  year = {2024},
  journal = {Eye},
  author = {Markle, Jonathan C and Johanis, Anil and Shaia, Jacqueline K. and Benito, Daniel and Talcott, Katherine E. and Singh, Rishi P.}
}


Share
Tools
Translate to